|
September 2025 PSORIATIC ARTHRITIS HIGHLIGHTS FROM EULAR 2025Eric M. Ruderman, MD, recently joined RheumNow to share key takeaways from the European Congress of Rheumatology EULAR 2025 meeting in Barcelona, Spain.
Deucravacitinib's Place in the PsA Treatment Algorithm?
Difficult to Treat Psoriatic Arthritis
Frequent dosing in PsA: Less or More?Psoriatic Arthritis Panel: EULAR 2025Using Combination csDMARDs in PsA |
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|
